Rigel Pharmaceuticals
RIGL
#6163
Rank
C$1.22 B
Marketcap
C$67.63
Share price
3.25%
Change (1 day)
106.39%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.17 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are C$0.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.23 B19.18%
2023-12-31C$0.19 B-3.59%
2022-12-31C$0.20 B14.98%
2021-12-31C$0.17 B79.28%
2020-12-31C$97.35 M-20.49%
2019-12-31C$0.12 B207.51%
2018-12-31C$39.81 M71.53%
2017-12-31C$23.21 M-25.24%
2016-12-31C$31.05 M-44.55%
2015-12-31C$55.99 M86.38%
2014-12-31C$30.04 M58.5%
2013-12-31C$18.95 M-9%
2012-12-31C$20.82 M-2.29%
2011-12-31C$21.31 M3.71%
2010-12-31C$20.55 M-36.73%
2009-12-31C$32.48 M-32.68%
2008-12-31C$48.26 M43.95%
2007-12-31C$33.52 M10.7%
2006-12-31C$30.28 M-33.44%
2005-12-31C$45.49 M42.83%
2004-12-31C$31.85 M57.91%
2003-12-31C$20.17 M-32.42%
2002-12-31C$29.85 M7.04%
2001-12-31C$27.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sangamo Therapeutics
SGMO
C$0.11 B-34.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$94.67 B 54,720.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
C$111.31 B 64,356.27%๐Ÿ‡บ๐Ÿ‡ธ USA